William D. Clark, Senior VP, Chief Business Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 3,000 shares at $20.05 ($60K) on 2007-06-01, disclosed to the SEC on 2007-06-04.
Scheduled sale ($60k) by Senior VP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.01 | 194 | $4K | 6.4% |
| 2 | $20.02 | 100 | $2K | 3.3% |
| 3 | $20.05 | 200 | $4K | 6.6% |
| 4 | $20.07 | 500 | $10K | 16.6% |
| 5 | $20.10 | 200 | $4K | 6.7% |
| 6 | $20.11 | 100 |
| $2K |
| 3.3% |
| 7 | $20.12 | 1,120 | $23K | 37.3% |
| 8 | $20.17 | 100 | $2K | 3.3% |
| 9 | $20.19 | 100 | $2K | 3.3% |
| 10 | $20.21 | 100 | $2K | 3.3% |
| 11 | $20.22 | 12 | $243 | 0.4% |
| 12 | $20.23 | 174 | $4K | 5.8% |
| 13 | $20.24 | 100 | $2K | 3.4% |
| Total | $20.11 avg | 3,000 | $60K | 100% |
| Filing → |
| GNCA | SELL | 2022-06-02 | $7K | — | Filing → |
| GNCA | SELL | 2022-04-05 | $5K | — | Filing → |
| GNCA | SELL | 2022-03-17 | $13K | — | Filing → |